Restenosis - Pipeline Review, H1 Industry Size, Development and Growth Report To 2017
Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H1 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family history or race and diabetes. Treatment includes surgery and thrombolytic therapy. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Restenosis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Restenosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and late...